LONDON, 20 April 2007 – Hikma Pharmaceuticals PLC, the multinational pharmaceuticals group, announces that it has agreed to acquire Thymoorgan GmbH Pharmazie & Co. KG (“Thymoorgan”), a German contract manufacturer of lyophilised and liquid injectables for both oncological and non-oncological uses.
